Literature DB >> 8434822

Kinetics of immobilized heparinase in human blood.

L E Freed1, G V Vunjak-Novakovic, H Bernstein, C L Cooney, R Langer.   

Abstract

Immobilized enzyme reactors can form the basis of useful blood detoxification systems. One such reactor was developed for heparin neutralization by immobilized heparinase. In this article, reactor kinetics were studied under clinically relevant conditions. Heparin neutralization was assessed in vitro in whole human blood using (a) a well-mixed batch reactor, and (b) an oscillating, continuous-flow reactor. The kinetics of heparin neutralization in human blood were first order over the entire range of heparin and enzyme concentrations and particle fractions tested. The kinetic rate was not sensitive to physiological variations in the concentration of antithrombin, a heparin binding protein in blood. Enzyme activity did not decrease significantly over the 2 hour test period. Kinetic control of the system with minimal intraparticle diffusional limitations was suggested by the Thiele moduli (0.11-0.67) and effectiveness factors (0.98 +/- 0.01). The ratio kcat/Km obtained in batch studies was 0.0028 +/- 0.0008 cm3/microgram-min. A continuous-flow oscillating reactor within a closed recirculation loop performed as a single well mixed batch reactor; there was a short mixing time of recirculating blood when compared to reaction time. A model based on this mixing pattern and the kinetics obtained in independent batch studies accurately predicted heparin neutralization profiles observed in the continuous-flow system.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8434822     DOI: 10.1007/bf02368166

Source DB:  PubMed          Journal:  Ann Biomed Eng        ISSN: 0090-6964            Impact factor:   3.934


  13 in total

1.  Specific hemoperfusion through agarose acrobeads.

Authors:  S Margel; L Marcus
Journal:  Appl Biochem Biotechnol       Date:  1986-02       Impact factor: 2.926

2.  Ex vivo model of an immobilized-enzyme reactor.

Authors:  H Bernstein; R Langer
Journal:  Proc Natl Acad Sci U S A       Date:  1988-11       Impact factor: 11.205

3.  Diffusion and chemical transformation.

Authors:  P B Weisz
Journal:  Science       Date:  1973-02-02       Impact factor: 47.728

4.  Immunochemical quantitation of antigens by single radial immunodiffusion.

Authors:  G Mancini; A O Carbonara; J F Heremans
Journal:  Immunochemistry       Date:  1965-09

5.  Bioreactor based on suspended particles of immobilized enzyme.

Authors:  L E Freed; G V Vunjak-Novakovic; P A Drinker; R Langer
Journal:  Ann Biomed Eng       Date:  1993       Impact factor: 3.934

6.  The kinetics of hemostatic enzyme-antithrombin interactions in the presence of low molecular weight heparin.

Authors:  R E Jordan; G M Oosta; W T Gardner; R D Rosenberg
Journal:  J Biol Chem       Date:  1980-11-10       Impact factor: 5.157

7.  Differential anticoagulant activity of heparin fragments prepared using microbial heparinase.

Authors:  R J Linhardt; A Grant; C L Cooney; R Langer
Journal:  J Biol Chem       Date:  1982-07-10       Impact factor: 5.157

8.  An enzymatic system for removing heparin in extracorporeal therapy.

Authors:  R Langer; R J Linhardt; S Hoffberg; A K Larsen; C L Cooney; D Tapper; M Klein
Journal:  Science       Date:  1982-07-16       Impact factor: 47.728

Review 9.  Protamine: a review of its toxicity.

Authors:  J C Horrow
Journal:  Anesth Analg       Date:  1985-03       Impact factor: 5.108

10.  Purification and characterization of heparinase from Flavobacterium heparinum.

Authors:  V C Yang; R J Linhardt; H Bernstein; C L Cooney; R Langer
Journal:  J Biol Chem       Date:  1985-02-10       Impact factor: 5.157

View more
  1 in total

1.  Bioreactor based on suspended particles of immobilized enzyme.

Authors:  L E Freed; G V Vunjak-Novakovic; P A Drinker; R Langer
Journal:  Ann Biomed Eng       Date:  1993       Impact factor: 3.934

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.